OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Virology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
A structural view of the SARS-CoV-2 virus and its assembly	157
The morphogenesis of different giant viruses as additional evidence for a common origin of Nucleocytoviricota	134
Alohomora! What the entry mechanisms tell us about the evolution and diversification of giant viruses and their hosts	106
Unresolved questions in the zoonotic transmission of MERS	68
The enigmatic roles of Anelloviridae and Redondoviridae in humans	66
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success	64
Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines	63
Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response	59
Editorial Board	57
Editorial overview: The virome in health and disease (2022)	57
Asymmetry in icosahedral viruses	56
Publisher Note - Virtual Special Issue	55
Editorial Board	55
Editorial Board	53
Editorial Board	51
Editorial Board	50
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	47
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	44
Editorial Board	44
Origin and fine-tuning of effector CD8 T cell subpopulations in chronic infection	40
Editorial overview: Special issue on antiviral strategies in Current Opinion in Virology	40
Editorial overview: Engineering elimination of chronic viral hepatitis	40
Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals	37
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses	37
Antivirals targeting paramyxovirus membrane fusion	36

Inhaled aerosol viral-vectored vaccines against tuberculosis	35
Immunity to acute virus infections with advanced age	34
Cryo-electron microscopy of nodavirus RNA replication organelles illuminates positive-strand RNA virus genome replication	32
Seeing and touching adenovirus: complementary approaches for understanding assembly and disassembly of a complex virion	32
Structural insights into hepatitis C virus neutralization	31
When good turns bad: how viruses exploit innate immunity factors	31
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?	30
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	30
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19	30
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification	29
The influence of microbiota-derived metabolites on viral infections	29
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	28
Role of trained innate immunity against mucosal cancer	28
Immune–bacteriophage interactions in inflammatory bowel diseases	28
Tissue-resident memory T cells in protective immunity to influenza virus	28
Mutational escape from cellular immunity in viral hepatitis: variations on a theme	28
Gradual adaptation of animal influenza A viruses to human-type sialic acid receptors	27
Host cell-intrinsic innate immune recognition of SARS-CoV-2	26
Current challenges to virus discovery by meta-transcriptomics	26
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	26
Future considerations for the mRNA-lipid nanoparticle vaccine platform	24
Retasking of canonical antiviral factors into proviral effectors	23
Hepatitis B virus–host interactions and novel targets for viral cure	23
Cell-to-cell movement of plant viruses via plasmodesmata: a current perspective on potyviruses	23
Plant negative-stranded RNA virus biology and host interactions revitalized by reverse genetics	23
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	22
Immune system control of hepatitis C virus infection	22
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	22
Transmission patterns of hepatitis E virus	21
Host–pathogen interactions of emerging zoonotic viruses: bats, humans and filoviruses	21
Editorial overview: Viral pathogenesis	21
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	21
Editorial overview: Special issue on virus structure and expression in current opinion in virology	21
Quantitative measures of within-host viral genetic diversity	21
Barriers to hepatitis C virus infection in mice	20
Virus-host interactions during tick-borne bunyavirus infection	20
Editorial overview: Virus structure and expression	20
T cell responses during HBV and HCV infections: similar but not quite the same?	19
Structural basis for neutralization of enterovirus	19
The intestinal virome: lessons from animal models	19
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma	18
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses	18
Structural basis for respiratory syncytial virus and human metapneumovirus neutralization	18
Non-structural protein 5 (NS5) as a target for antiviral development against established and emergent flaviviruses	18
Mechanisms of HCV resistance to broadly neutralizing antibodies	18
Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine	17
Fighting viruses with computers, right now	16
Immune responses to human respiratory coronaviruses infection in mouse models	16
Immunotherapy for KSHV-associated diseases	16
Detection of viruses by inflammasomes	16

Editorial overview: Viruses and Cancer	16
Proteases and variants: context matters for SARS-CoV-2 entry assays	15
Assembly of the virome in newborn human infants	15
Microbiota-immune system interactions and enteric virus infection	15
Structural perspectives on HCV humoral immune evasion mechanisms	15
Role of the intestinal microbiota in host defense against respiratory viral infections	15
Fishing for phages in metagenomes: what do we catch, what do we miss?	15
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets	15
Natural killer cells and unconventional T cells in COVID-19	14
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	14
Virus–host protein interactions as footprints of human cytomegalovirus replication	14
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	14
Teaching old dogmas new tricks: recent insights into the nuclear import of HIV-1	13
The virome of vector mosquitoes	13
Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity	13
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	13
Modeling zoonotic and vector-borne viruses	13
Oncogenic Animal Herpesviruses	13
Global overview and major challenges of host prediction methods for uncultivated phages	13
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	13
UPR signaling at the nexus of plant viral, bacterial, and fungal defenses	13
The gut virome in inflammatory bowel diseases	13
Editorial overview: The lung, the gut, and the genital mucosae: microbial targets and therapeutic playgrounds	12
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	12
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	12
Deimmunization of flagellin adjuvant for clinical application	12
Lying low-chromatin insulation in persistent DNA virus infection	12
HIV persistence: silence or resistance?	11
Broad neutralizing antibody-based strategies to tackle influenza	11
Innate immunity and HBV persistence	11
HIV-1 entry: Duels between Env and host antiviral transmembrane proteins on the surface of virus particles	11
Virus genomics: what is being overlooked?	10
Bat virome research: the past, the present and the future	10
SARS-CoV-2 vaccines — the biggest medical research project of the 21st century	10
Transmembrane redox regulation of genome replication functions in positive-strand RNA viruses	10
Sending mixed signals: polyomavirus entry and trafficking	10
Remdesivir for the treatment of Covid-19: the value of biochemical studies	10
Arms race between rice and viruses: a review of viral and host factors	10
Antigenic evolution of SARS coronavirus 2	10
Anti-viral protective capacity of tissue resident memory T cells	10
Editorial Board	9
Editorial Board	9
Hepatitis B virus e antigen and viral persistence	9
Ribosomes in poxvirus infection	9
Cryo-electron tomography of viral infection — from applications to biosafety	9
Editorial overview: Mechanisms in the molecular interactions of plants with viruses and viroids	9
The interplay between capsid dynamics and pathogenesis in tripartite bromoviruses	9
Editorial Board	9
European regulatory aspects of phage therapy: magistral phage preparations	9
Host defence and persistent human papillomavirus infection	9
Editorial Board	9
The impact of high-resolution structural data on stemming the COVID-19 pandemic	9
Digital phagograms: predicting phage infectivity through a multilayer machine learning approach	9
Editorial Board	9
Cytotoxicity in Epstein Barr virus specific immune control	9
Koala retrovirus and neoplasia: correlation and underlying mechanisms	9
Advances in human monoclonal antibody therapy for HBV infection	8
Current view and perspectives in viroid replication	8
Phage banks as potential tools to rapidly and cost-effectively manage antimicrobial resistance in the developing world	8
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2	8
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination	8
Phage therapy for secondary bacterial infections with COVID-19	8
Measles immunity and immunosuppression	8
Recent advances in understanding plant antiviral RNAi and viral suppressors of RNAi	8
Immunotherapy and therapeutic vaccines for chronic HBV infection	8
Structure and function of SARS-CoV-2 polymerase	8
Recent progress in development of monoclonal antibodies against human cytomegalovirus	8